Sean Brynjelsen - President & CEO, Director at Eton Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
ETON on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sean Brynjelsen since 4/23/2024

Holdings reported by Sean Brynjelsen for Eton Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 72K $575K $7.98 Jan 3, 2025 Direct Common Stock
Stock Option (Right to buy) 2.47M Feb 13, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 107K Jan 3, 2025 Direct Common Stock

Transactions reported by Sean Brynjelsen for Eton Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.